Integra LifeSciences Holdings PE Ratio 2010-2024 | IART
Current and historical p/e ratio for Integra LifeSciences Holdings (IART) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Integra LifeSciences Holdings PE ratio as of September 10, 2024 is 6.21.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Integra LifeSciences Holdings PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2024-09-10 | 17.72 | 61.10 | |
| 2024-06-30 | 29.14 | $0.29 | 100.48 |
| 2024-03-31 | 35.45 | $0.50 | 70.90 |
| 2023-12-31 | 43.55 | $0.83 | 52.47 |
| 2023-09-30 | 38.19 | $1.21 | 31.56 |
| 2023-06-30 | 41.13 | $1.57 | 26.20 |
| 2023-03-31 | 57.41 | $2.06 | 27.87 |
| 2022-12-31 | 56.07 | $2.16 | 25.96 |
| 2022-09-30 | 42.36 | $2.06 | 20.56 |
| 2022-06-30 | 54.03 | $1.97 | 27.43 |
| 2022-03-31 | 64.26 | $1.84 | 34.92 |
| 2021-12-31 | 66.99 | $1.98 | 33.83 |
| 2021-09-30 | 68.48 | $2.54 | 26.96 |
| 2021-06-30 | 68.24 | $2.41 | 28.32 |
| 2021-03-31 | 69.09 | $2.00 | 34.55 |
| 2020-12-31 | 64.92 | $1.58 | 41.09 |
| 2020-09-30 | 47.22 | $0.67 | 70.48 |
| 2020-06-30 | 46.99 | $-0.03 | 0.00 |
| 2020-03-31 | 44.67 | $0.31 | 144.10 |
| 2019-12-31 | 58.28 | $0.58 | 100.48 |
| 2019-09-30 | 60.07 | $0.69 | 87.06 |
| 2019-06-30 | 55.85 | $1.16 | 48.15 |
| 2019-03-31 | 55.72 | $0.96 | 58.04 |
| 2018-12-31 | 45.10 | $0.72 | 62.64 |
| 2018-09-30 | 65.87 | $0.99 | 66.54 |
| 2018-06-30 | 64.41 | $0.88 | 73.19 |
| 2018-03-31 | 55.34 | $0.88 | 62.89 |
| 2017-12-31 | 47.86 | $0.82 | 58.37 |
| 2017-09-30 | 50.48 | $0.61 | 82.75 |
| 2017-06-30 | 54.51 | $0.82 | 66.48 |
| 2017-03-31 | 42.13 | $0.84 | 50.15 |
| 2016-12-31 | 42.90 | $0.92 | 46.88 |
| 2016-09-30 | 41.28 | $0.76 | 54.31 |
| 2016-06-30 | 39.89 | $0.06 | 664.83 |
| 2016-03-31 | 33.68 | $-0.03 | 0.00 |
| 2015-12-31 | 33.89 | $-0.06 | 0.00 |
| 2015-09-30 | 29.78 | $0.01 | 2978.00 |
| 2015-06-30 | 30.59 | $0.61 | 50.15 |
| 2015-03-31 | 28.00 | $0.61 | 45.89 |
| 2014-12-31 | 24.63 | $0.52 | 47.36 |
| 2014-09-30 | 22.54 | $0.46 | 49.00 |
| 2014-06-30 | 21.37 | $-0.20 | 0.00 |
| 2014-03-31 | 20.88 | $-0.22 | 0.00 |
| 2013-12-31 | 21.67 | $-0.33 | 0.00 |
| 2013-09-30 | 18.28 | $-0.30 | 0.00 |
| 2013-06-30 | 16.63 | $0.45 | 37.38 |
| 2013-03-31 | 17.71 | $0.54 | 33.11 |
| 2012-12-31 | 17.70 | $0.73 | 24.41 |
| 2012-09-30 | 18.66 | $0.58 | 32.46 |
| 2012-06-30 | 16.88 | $0.54 | 31.27 |
| 2012-03-31 | 15.75 | $0.40 | 39.38 |
| 2011-12-31 | 14.00 | $0.48 | 29.47 |
| 2011-09-30 | 16.24 | $0.71 | 22.88 |
| 2011-06-30 | 21.71 | $0.79 | 27.48 |
| 2011-03-31 | 21.53 | $1.03 | 20.91 |
| 2010-12-31 | 21.48 | $1.09 | 19.71 |
| 2010-09-30 | 17.92 | $1.04 | 17.23 |
| 2010-06-30 | 16.80 | $1.01 | 16.64 |
| 2010-03-31 | 19.90 | $0.95 | 20.95 |
| 2009-12-31 | 16.74 | $0.86 | 19.47 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.363B | $1.542B |
| Integra LifeSciences is one of the world leaders in regenerative medicine. The company develops, manufactures and markets cost-effective surgical implants and medical instruments. The company now manufactures and sells products in the following two global reportable business segments: Codman Specialty Surgical (CSS) and Orthopedics and Tissue Technologies (OTT). The CSS business offers global, market-leading technologies, brands and instrumentation. The global commercial network includes clinical specialists, a large direct global sales force and strategic partnerships and distributors that serve hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers and health care providers in North America, South America, Europe, Asia Pacific, Middle East and Africa. The Tissue Technologies segment includes wound reconstruction and repair products, bone grafts and nerve and tendon repair products. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $236.998B | 28.41 |
| Intuitive Surgical (ISRG) | United States | $170.353B | 96.46 |
| Alcon (ALC) | Switzerland | $47.593B | 33.50 |
| IQVIA Holdings (IQV) | United States | $43.911B | 24.88 |
| Edwards Lifesciences (EW) | United States | $39.584B | 25.37 |
| IDEXX Laboratories (IDXX) | United States | $39.535B | 47.56 |
| DexCom (DXCM) | United States | $27.935B | 39.83 |
| STERIS (STE) | Ireland | $24.210B | 28.25 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.865B | 0.00 |
| Waters (WAT) | United States | $19.714B | 29.39 |
| Hologic (HOLX) | United States | $19.207B | 20.88 |
| Sysmex ADR (SSMXY) | Japan | $11.893B | 37.29 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $11.672B | 13.09 |
| Teleflex (TFX) | United States | $11.546B | 17.95 |
| Globus Medical (GMED) | United States | $9.481B | 26.52 |
| Penumbra (PEN) | United States | $7.578B | 78.66 |
| Glaukos (GKOS) | United States | $7.111B | 0.00 |
| Masimo (MASI) | United States | $5.924B | 31.73 |
| TransMedics (TMDX) | United States | $4.647B | 199.01 |
| Integer Holdings (ITGR) | United States | $4.172B | 24.40 |
| PROCEPT BioRobotics (PRCT) | United States | $3.984B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.765B | 0.00 |
| Inari Medical (NARI) | United States | $2.601B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.557B | 15.00 |
| Nihon Kohden (NHNKY) | Japan | $2.375B | 14.78 |
| Elekta AB (EKTAY) | Sweden | $2.347B | 19.12 |
| Veracyte (VCYT) | United States | $2.234B | 138.48 |
| RxSight (RXST) | United States | $1.981B | 0.00 |
| Silk Road Medical (SILK) | United States | $1.100B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.099B | 19.60 |
| OPKO Health (OPK) | United States | $1.088B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.075B | 0.00 |
| Artivion (AORT) | United States | $1.020B | 93.65 |
| Alphatec Holdings (ATEC) | United States | $0.794B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.741B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.653B | 16.50 |
| SiBone (SIBN) | United States | $0.627B | 0.00 |
| Paragon 28 (FNA) | United States | $0.626B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.612B | 0.00 |
| AxoGen (AXGN) | United States | $0.571B | 0.00 |
| IRadimed (IRMD) | United States | $0.570B | 30.82 |
| Pacific Biosciences Of California (PACB) | United States | $0.452B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.327B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.323B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.321B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.308B | 9.39 |
| AngioDynamics (ANGO) | United States | $0.292B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.272B | 0.00 |
| Inogen (INGN) | United States | $0.269B | 0.00 |
| NeuroPace (NPCE) | United States | $0.206B | 0.00 |
| Accuray (ARAY) | United States | $0.199B | 0.00 |
| Nevro (NVRO) | United States | $0.180B | 0.00 |
| CVRx (CVRX) | United States | $0.173B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.171B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.165B | 11.58 |
| Alpha Tau Medical (DRTS) | Israel | $0.156B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.141B | 0.00 |
| 908 Devices (MASS) | United States | $0.121B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.114B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.113B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.095B | 14.15 |
| Monogram Orthopaedics (MGRM) | United States | $0.090B | 0.00 |
| Hyperfine (HYPR) | United States | $0.073B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.073B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.073B | 0.00 |
| InspireMD (NSPR) | Israel | $0.070B | 0.00 |
| Envoy Medical (COCH) | United States | $0.064B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.056B | 0.00 |
| LENSAR (LNSR) | United States | $0.055B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.047B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.043B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.037B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.035B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.035B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.032B | 0.00 |
| ReWalk Robotics (LFWD) | United States | $0.027B | 0.00 |
| DarioHealth (DRIO) | United States | $0.025B | 0.00 |
| Spectral AI (MDAI) | United States | $0.024B | 0.00 |
| Neuronetics (STIM) | United States | $0.024B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.021B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.021B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.017B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.015B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.015B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.014B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.014B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.011B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.003B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Tenon Medical (TNON) | United States | $0.002B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |